Munich, Germany

Dirk Weber

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2006.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk Weber: Innovator in Isoquinoline Derivatives

Introduction

Dirk Weber is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his work on isoquinoline derivatives. His innovative approach has led to advancements in the treatment of various medical conditions.

Latest Patents

Dirk Weber holds a patent for isoquinoline derivatives, which are defined by the general formula (I) in which X, Y, Z, R, and n are specified in the patent claim. These compounds act as integrin inhibitors and have potential applications in combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections, and restenosis after angioplasty. The physiologically acceptable salts or solvates of these derivatives further enhance their therapeutic potential.

Career Highlights

Dirk Weber is associated with Merck Patent GmbH, where he has been instrumental in advancing research and development in his field. His work has not only contributed to the scientific community but has also paved the way for new treatment options for patients suffering from serious health conditions.

Collaborations

Throughout his career, Dirk has collaborated with esteemed colleagues such as Matthias Wiesner and Simon Lawrence Goodman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Dirk Weber's contributions to the field of isoquinoline derivatives exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in therapeutic solutions for various diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…